Skip to main content
Premium Trial:

Request an Annual Quote

Vertex Pharmaceuticals Subscribes to Deltagen s DeltaBase

NEW YORK, May 8 - Vertex Pharmaceuticals has contracted with Deltagen for access to part of DeltaBase, the companies said Tuesday.

The subscription will allow Vertex to obtain in vivo mammalian gene function on kinases, proteases, and other commercially-relevant gene families, according to a statement.

Vertex will have intellectual property rights to commercialize pharmaceutical products based on the research. In exchange, Deltagen will receive milestone and royalty payments. The agreement is for three years, with the option to extend for an additional two.

In a subscription arrangement with Pfizer signed last year, Deltagen charged $15 million for a three-year license. GlaxoSmithKline also has a subscription for DeltaBase, a database of functional and phenotypic information on mammalian genes obtained from mouse models.

"This genomic information will contribute to our biological understanding of specific proteins within several target-rich gene families, and will complement our parallel, small molecule drug design programs," Vicki Sato, president of Vertex, said in a statement.

Last week, Vertex acquired Aurora Biosciences, a manufacturer and provider of cell-based assay and high-throughput testing systems, for $592 million in stock.

 

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.